- |||||||||| MK-1697 / Merck (MSD)
Enrollment change, Trial termination, Metastases: Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001) (clinicaltrials.gov) - Mar 10, 2020
P1, N=22, Terminated,
The findings may add to our understanding of the diversity of soft rot pathogens affecting carrot production in Taiwan. N=122 --> 22 | Active, not recruiting --> Terminated; Business Reasons
- |||||||||| MK-1697 / Merck (MSD)
Enrollment closed, Trial completion date, Trial primary completion date, Metastases: Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001) (clinicaltrials.gov) - Jan 18, 2020
P1, N=122, Active, not recruiting,
N=122 --> 22 | Active, not recruiting --> Terminated; Business Reasons Recruiting --> Active, not recruiting | Trial completion date: Sep 2022 --> Feb 2020 | Trial primary completion date: Sep 2022 --> Feb 2020
- |||||||||| MK-1697 / Merck (MSD)
Trial completion date, Trial primary completion date, Metastases: Study of MK-1697 in Participants With Advanced Solid Tumors (MK-1697-001) (clinicaltrials.gov) - Mar 19, 2019
P1, N=122, Recruiting,
Recruiting --> Active, not recruiting | Trial completion date: Sep 2022 --> Feb 2020 | Trial primary completion date: Sep 2022 --> Feb 2020 Trial completion date: Aug 2021 --> Sep 2022 | Trial primary completion date: Aug 2021 --> Sep 2022
|
